FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/067335 [Registered on: 14/05/2024] Trial Registered Prospectively
Last Modified On: 23/04/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Therapeutic]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Kashtartava (Primary Dysmenorrhoea) - Ayurvedic management with Shatavari Taila Matrabasti and Tila Taila Matrabasti 
Scientific Title of Study   A Randomized Controlled Trial to evaluate the efficacy of Shatavari Taila Matrabasti in the management of Kashtartava with special reference to Primary Dysmenorrhoea. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Preeti Kshitij Jadhav 
Designation  PhD Scholar 
Affiliation  Government Ayurved College and Hospital , Nagpur 
Address  Government Ayurved College, Department of Prasutitantra-Streerog, 2nd Floor, Raje Raghuji Nagar, Umred Road, Sakkardara, Nagpur

Nagpur
MAHARASHTRA
440024
India 
Phone  9422210229  
Fax    
Email  dr.preetikjadhav@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Manoj V Gaikwad 
Designation  Professor & HOD ( PhD Guide) 
Affiliation  R.A. Podar Ayurved Medical College and Hospital 
Address  R.A. Podar Ayurved Medical College, Department of Prasutitantra and Streerog, Annie Besant Road, Worli, Mumbai

Mumbai
MAHARASHTRA
400018
India 
Phone  9822752816  
Fax    
Email  drmanojvgaikwad@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr. Preeti Kshitij Jadhav 
Designation  PhD Scholar 
Affiliation  Government Ayurved College and Hospital , Nagpur 
Address  Government Ayurved College, Department of Prasutitantra-Streerog, 2nd Floor, Raje Raghuji Nagar, Umred Road, Sakkardara, Nagpur

Nagpur
MAHARASHTRA
440024
India 
Phone  9422210229  
Fax    
Email  dr.preetikjadhav@gmail.com  
 
Source of Monetary or Material Support  
Government Ayurved College and Hospital, Nagpur 
 
Primary Sponsor  
Name  Dr Preeti Kshitij Jadhav 
Address  Government Ayurved College and Hospital, Raje Raghuji Nagar, Umred Road, Sakkardara, Nagpur 440024 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Preeti Kshitij Jadhav  Government Ayurved College and Hospital, Nagpur  OPD No. 42, Department of Prasutitantra and Streeroga, Raje Raghuji Nagar,Umred Road, Sakkardara, Nagpur 440024
Nagpur
MAHARASHTRA 
9422210229

dr.preetikjadhav@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC, Government Ayurved College,Nagpur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N944||Primary dysmenorrhea. Ayurveda Condition: YONIROGAH/YONI-VYAPADAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmProcedure-mAtrAbastiH, मात्राबस्तिः (Procedure Reference: Charak Samhita, Procedure details: Tila Taila Matrabasti 60 ml Once a day for 7 days before commencement of menses for 3 menstrual cycles)
(1) Medicine Name: Tila Taila , Reference: Bhavprakash Nighantu, Taila varga, Route: Rectal, Dosage Form: Taila, Dose: 60(ml), Frequency: od, Duration: 7 Days
2Intervention ArmProcedure-mAtrAbastiH, मात्राबस्तिः (Procedure Reference: Charak Samhita, Procedure details: Shatavari Taila Matrabasti 60 ml Once a day for 7 days before commencement of menses for 3 menstrual cycles)
(1) Medicine Name: Shatavari Taila, Reference: Kashyap Samhita, Route: Rectal, Dosage Form: Taila, Dose: 60(ml), Frequency: od, Duration: 7 Days
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  24.00 Year(s)
Gender  Female 
Details  1. Patients coming with complaint of painful
menses.
2. Adolescent girls of age between 18 to 24 years.
3. Patients suffering from Kashtartava for at
least 3 consecutive regular menstrual cycles.
4. Patient who agrees to participate and is ready
to sign the informed consent form.
 
 
ExclusionCriteria 
Details  1. Patients below 18 years and above 24 years.
2. Married women.
3. Patients of Secondary dysmenorrhoea.
4. Patients having congenital anomaly of
reproductive tract like hypoplastic uterus.
5. Patients having organic pathology of uterus and
adnexa like fibroid uterus, carcinoma of
endometrium.
6. Patients with Dysfunctional uterine bleeding,
Pelvic Inflammatory diseases, Endometritis.
7. Patients having conditions where surgical
intervention should be needed.
8.Patients with systemic diseases.
9.Patients taking hormonal therapy.
10.Patient who is not willing to give informed
consent.
 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To evaluate the efficacy of Shatavari Taila Matrabasti in the management of Kashtartava with special reference to Primary Dysmenorrhea on VAS scale  before treatment (on day 1 and day 5)and after treatment (on day 1 and day 5) 
 
Secondary Outcome  
Outcome  TimePoints 
Effect of Shatavari Taila Matrabasti on reduction in intensity & duration of pain present in Kashtartava with special referance to Primary Dysmenorrhea  before treatment (on day 1 & day 5)and after treatment (on day 1 & day 5) 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is randomized, parallel group, open labelled, controlled clinical trial to evaluate and compare the efficacy of Shatavari Taila Matrabasti and Tila Taila Matrabasti in Kashtartava with special referance to Primary Dysmenorrhea. Study Population- Adolescent girls of age 18-24 years having symptoms of Kashtartava.120 patients of Kashtartava from OPD, IPD and Casualty of Govt. Ayurved Hospital, Nagpur will be taken. They will be divided into two groups by the random number table method. The trial group will be administered Shatavari Taila Matrabasti 60 ml once a day for 7 days before commencement of menses for 3 consecutive menstrual cycles and the comparison group will be administered Tila Taila Matrabasti 60 ml once a day before commencement of menses for 3 consecutive menstrual cycles. Comparison of the effects on the subjective parameters before and after treatment between two groups  will be done. Follow-ups will be done. The results will be analyzed statistically to draw conclusions from the study.
 
Close